As of Friday, January 23, Burning Rock Biotech Limited’s BNR share price has dipped by 9.56%, which has investors questioning if this is right time to buy.

Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, ...

“BNR” and “Balloon” continue to mark Crumb’s growth since their already-impressive 2019 debut album. Eerie and enthralling, the siren song of frontwoman Lila Ramani captures attention against the ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...